September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Inadequate Vitamin D May Increase Risk of Certain Rheumatic Diseases
While substantial evidence already shows several genetic and environmental elements factor into immune-mediated rheumatic disease susceptibility, a recent review of hospital admissions data suggests vitamin D deficiency can single-handedly elevate a patient's risk of developing certain chronic conditions within that group of disorders.
Inflammatory Cell Counts in Gout Tissues Closely Linked to Hypertension Presence
A pair of researchers based in Texas has gained valuable insight into the correlation between individual cell type in the tissues of gout patients and comorbidity factors of the chronic inflammatory autoimmune disorder.
Extreme Glycemic Control Not Significantly Associated with Increased All-Cause Mortality
June 24th 2013While the current ADA guidelines recommend targeting HbA1c levels to below 8% for high-risk patients with diabetes, reducing the level to 5.7% dose not raise CVD or overall mortality risk, according to a recent study.
Combination Liraglutide and Insulin Degludec Is Safe and Effective in Type 2 Diabetes
June 23rd 2013Study shows a combination of liraglutide and the genetically modified insulin analog degludec was safe and improved HbA1c levels, weight loss, and hypoglycemia outcomes in patients with type 2 diabetes.
The Educated Patient® Diabetes Resource Guide
June 21st 2013The Diabetes Resource Guide highlights 20 websites that feature articles on topics such as ways to address and improve lifestyle factors (such as diet), how to live day to day with diabetes, information about diabetes medications, online forums, and more.
Nonalcoholic Fatty Liver Disease Boosts Cardiovascular Risk, But Lacks Management Plan
May 21st 2013Growing evidence suggests increased cardiovascular risk in patients with nonalcoholic fatty liver disease (NAFLD) - in particular nonalcoholic steatohepatitis (NASN) - but no data exists to support a specific management approach.
New Diabetes Management Guidelines Consider Concurrent Conditions
In diagnosing a patient with type 2 diabetes, an endocrinologist or primary care physician may struggle with developing healthy treatment targets when comorbid conditions like obesity and hypoglycemia are at play.
Looking for Effective Treatment Options for Painful Diabetic Peripheral Neuropathy
March 23rd 2013Severe neuropathic pain due to diabetic peripheral neuropathy is associated with negative health impact and increased healthcare utilization, underscoring the need for the development of safe and effective treatments.